Computational Strategies for Drug Reprofiling

This article introduces some of the recent developments in drug re-profiling with emphasis on how computational chemistry and biology approaches together with access to public databases can help generate new leads from existing drugs. It discusses the drawbacks of high-throughput (HTS) genomics and how the concepts of target polypharmacology can help speed up delivery of the next generation of drugs. Some of the successful strategies for drug re-profiling are presented and computational tools are discussed.